Surfactant and varespladib co-administration in stimulated rat alveolar macrophages culture

Current Pharmaceutical Biotechnology

Volumn 14, Issue 4, 2013, Pages 445-448

  De Luca, Daniele ^a   Vendittelli, Francesca ^a   Trias, Joaquim ^b   Fraser, Heather ^b   Minucci, Angelo ^a   Gentile, Leonarda ^a   Perez Gil, Jesus ^c   Conti, Giorgio ^a   Antonelli, Massimo ^a   Capoluongo, Ettore D ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b Anthera Pharmaceuticals   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acute lung injury; Secretory phospholipase A2; Surfactant; Varespladib

Indexed keywords

FATTY ACID; PHOSPHOLIPASE A2; PORACTANT; TUMOR NECROSIS FACTOR ALPHA; VARESPLADIB;

ACUTE LUNG INJURY; ANIMAL CELL; ARTICLE; CALORIMETRY; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID METABOLISM; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; RAT;

ACETATES; ACUTE LUNG INJURY; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; INDOLES; MACROPHAGES, ALVEOLAR; PHOSPHOLIPASES A2, SECRETORY; PULMONARY SURFACTANTS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 84878788031     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314040010     Document Type: Article

References (17)

1. Cross, L.J.; Matthay, M.A. Biomarkers in acute lung injury: in sights into the pathogenesis of acute lung injury. Crit. Care Clin., 2011, 27, 355-377.
2. Günther, A.; Ruppert, C.; Schmidt, R.; Markart, P.; Grimminger, F.; Walmrath, D.; Seeger W. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res., 2001, 2, 353-364.
3. Touqui, L.; Arbibe, L.; A role for phospholipase A2 in ARDS pathogenesis. Mol. Med. Today, 1999, 5, 244-249.
4. Nakos, G.; Kitsiouli, E.; Hatzidaki, E.; Koulouras, V.; Touqui, L.; Lekka, ME. Phospholipases A2 and platelet-activating-factor ace-tylhydrolase in patients with acute respiratory distress syndrome. Crit. Care Med., 2005, 33, 772-779.
5. De Luca, D.; Minucci, A.; Cogo, P.; Capoluongo, E.D.; Conti, G.; Pietrini, D.; Carnielli, V.P.; Piastra, M. Secretory phospholipase A2 pathway during pediatric acute respiratory distress syndrome: a preliminary study. Pediatr. Crit. Care Med., 2011, 12, e20-e24.
6. Berger, A.; Havet, N.; Vial, D.; Arbibe, L.; Dumarey, C.; Watson, M.L.; Touqui L. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. Am. J. Respir. Crit. Care Med., 1999, 159, 613-618.
7. Schevitz, R.W.; Bach, N.J.; Carlson, D.G.; Chirgadze, N.Y.; Clawson, D.K.; Dillard, R.D.; Draheim, S.E.; Hartley, L.W.; Jones, N.D.; Mihelich, E.D. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholi-pase A2. Nat. Struct. Biol., 1995, 2, 458-465.
8. Furue, S.; Kuwabara, K.; Mikawa, K.; Nishina, K.; Shiga, M.; Maekawa, N.; Ueno, M.; Chikazawa, Y.; Ono, T.; Hori, Y.; Matsukawa, A.; Yoshinaga, M.; Obara, H. Crucial role of group IIA Phospholipase A2 in oleic acid-induced acute lung injury in rabbits. Am. J. Resp. Crit. Care Med., 1999, 160, 1292-1302.
9. Furue, S.; Mikawa, K.; Nishina, K.; Shiga, M.; Ueno, M.; Tomita, Y.; Kuwabara, K.; Teshirogi, I.; Ono, T.; Hori, Y.; Matsukawa, A.; Yoshinaga, M.; Obara, H. Therapeutic time-window of a group IIA phospholipase inhibitor in rabbit acute lung injury: correlation with lung surfactant protection. Crit. Care Med., 2001, 29, 719-727.
10. Hidi, R.; Vial, D.; Havet, N.; Berger, A.; Vargaftig, B.B.; Touqui, L. Inhibition by pulmonary surfactant Curosurf of secretory phos-pholipase A2 expression in guinea-pig alveolar macrophages. Bio-chem. Pharmacol., 1997, 54, 1055-1058.
11. De Luca, D.; Minucci, A.; Trias, J.; Tripodi, D.; Conti, G.; Zuppi, C.; Capoluongo, E. Varespladib Inhibits Secretory Phospholipase A2 in Bronchoalveolar Lavage of Different Types of Neonatal Lung Injury. J. Clin. Pharmacol., 2012, 52, 729-737.
12. Matsubara, C.; Nishikawa, Y.; Yoshida, Y.; Takamura, K. A spec-trophotometric method for the determination of free fatty acid in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase. Anal. Biochem., 1983, 130, 128-133.
13. Zhang, Y.; Kouguchi, T.; Shimizu, K.; Sato, M.; Takahata, Y.; Morimatsu, F. Chicken collagen hydrolysate reduces proinflamma-tory cytokine production in C57BL/6.KOR-ApoEshl mice. J. Nutr. Sci. Vitaminol. (Tokyo), 2010, 56, 208-210.
14. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 1976, 72, 248-254.
15. Randolph A.G. Management of acute lung injury and acute respiratory distress syndrome in children. Crit. Care Med., 2009, 37, 2448-2454.
16. Arbibe, L.; Koumanov, K.; Vial, D.; Rougeot, C.; Faure, G.; Havet, N.; Longacre, S.; Vargaftig, B.B.; Béréziat, G.; Voelker, D.R.; Wolf, C.; Touqui, L. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J. Clin. Invest., 1998, 102, 1152-1160.
17. Taeusch, H.W.; Bernardino Serna J.; Perez-Gil, J.; Alonso, C.; Zasadzinski, J.A. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. Biophys. J., 2005, 89, 1769-1779.